WallStreetZenWallStreetZen

NASDAQ: KLRA
Kailera Therapeutics Inc Stock Ownership - Who owns Kailera Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kailera Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ronald C. Renaud Jr.CEO President2026-06-0938,094$5.25
$199.99kBuy
Bain Capital Investors LLC10% Owner2026-04-208,398,438$16.00
$134.38MBuy
Bain Capital Life Sciences Investors LLC10% Owner2026-04-201,562,500$16.00
$25.00MBuy
Andrew T. KaplanDirector2026-04-208,398,438$16.00
$134.38MBuy
Adam KoppelDirector2026-04-201,562,500$16.00
$25.00MBuy
Rtw Investments LP10% Owner2026-04-20500,000$16.00
$8.00MBuy

1 of 1

KLRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KLRA insiders and whales buy or sell their stock.

KLRA Shareholders

What type of owners hold Kailera Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew T. Kaplan20.25%26,255,581$426.13MInsider
Bain Capital Investors LLC20.25%26,255,581$426.13MInsider
Adam Koppel17.42%22,583,268$366.53MInsider
Bain Capital Life Sciences Investors LLC17.42%22,583,268$366.53MInsider
Rtw Investments LP8.31%10,776,820$174.91MInsider
Jiangsu Hengrui Pharmaceuticals Co Ltd1.57%2,034,134$33.01MInsider
Ronald C. Renaud Jr.0.03%38,094$618.27kInsider
Bainca0.02%26,256$426.13kInstitution
Bain Capital Investors LLC0.02%26,256$426.13kInstitution
Bain Capital Life Sciences Investors LLC0.02%22,583$366.52kInstitution

1 of 3

KLRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLRA0.09%85.25%Net BuyingNet Buying
GENB0.08%54.28%Net BuyingNet Selling
COAG0.08%20.30%Net BuyingNet Buying
ZYME0.10%93.89%Net SellingNet Buying
AUPH0.06%14.08%Net BuyingNet Selling
View Top Biotech Stocks

Kailera Therapeutics Stock Ownership FAQ

Who owns Kailera Therapeutics?

Kailera Therapeutics (NASDAQ: KLRA) is owned by 0.09% institutional shareholders, 85.25% Kailera Therapeutics insiders, and 14.66% retail investors. Andrew T. Kaplan is the largest individual Kailera Therapeutics shareholder, owning 26.26M shares representing 20.25% of the company. Andrew T. Kaplan's Kailera Therapeutics shares are currently valued at $426.13M.

If you're new to stock investing, here's how to buy Kailera Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.